In a Sept. 8, 2026 update, ASP Isotopes Inc. (NASDAQ: ASPI) said it hosted its inaugural capital markets day in London, with a presentation and question-and-answer session scheduled from 10:00 a.m. to 12:30 p.m. Eastern Time. The company said it is transitioning from building to producing in 2026 and outlined strategy across nuclear medicine, electronics, helium and LNG, and nuclear fuels.
ASP Isotopes said it expects to increase revenues as Phase 1 is completed and liquid helium production ramps up. The company also cited continued growth in radiopharmacies and first commercial shipments from its stable isotope division as key business milestones.
The company operates isotope enrichment facilities in Pretoria, South Africa. Tetra4 Proprietary Limited engages in the production and liquefaction of natural gas and helium resources at the Virginia Gas Plant in Free State Province, South Africa, and Renergen Limited holds a 94.5% equity ownership in Tetra4.
ASP Isotopes said it is targeting more than $300 million of EBITDA in 2031. Management also said it is continuing to pursue public listings of Quantum Leap Energy and Noble Africa as separate public companies.
